A team of eight Manchester businessmen are aiming to raise a million pounds for a mobile chemotherapy unit.
The team hope to cover 290 miles in just four days to raise the money which will bring cancer care directly into patients’ homes on behalf of The Christie.
The aptly named ‘Road2Recovery’ challenge will see all eight members of the team taking on five stages of the Tour De France this month.
The initiative was launched by the CEO of NCC, Rob Cotton and Mike Perls, CEO of MC2 and is part of a year-long campaign to raise £1million pounds for The Christie before April 2014.
Mike Perls, co-founder of Road2Recovery, said: “It’s really exciting to be working on the campaign with some great people for a wonderful charity. The Christie provides valuable support to cancer patients in the North West and mobile chemotherapy units will help it to deliver care much closer to the patient’s home.
“The Tour De France Challenge will be an incredibly difficult feat of physical and mental strength but a great experience and we are looking forward to challenging both our businesses and our bodies in order to raise money for such a worthy cause.”
PLEDGE: Mike Perls, Rob Cotton and Dr Andrew Wardsley aim to raise £1million
for a mobile chemotherapy unit
Dr Andrew Wardley, clinical lead for chemotherapy at The Christie, said: “This is an incredible challenge so huge thanks to Mike and Rob for leading the way.
“The mobile chemotherapy unit will be a great benefit to patients allowing them to have The Christie experience of specialized care and the best outcomes delivered close to where they live. It will make an enormous difference.
“The best of luck to everyone joining this campaign – all money raised will help cancer patients throughout Greater Manchester.”
The current raised balance stands at just over £155,000, and the five stages of the Tour De France will be from September 14-18.
For more information on the Road2Recovery challenge and how to get involved please visit: www.ontheroadtorecovery.co.uk.
For more on this story and many others, follow Mancunian Matters on Twitter and Facebook.
